Restitutive 20mg Vials

£110.00

Main Benefits

1. Significant Weight Loss

  • Among the most substantial weight reductions seen in any obesity medication to date

  • Some participants lost over 24% of body weight at 48 weeks

  • Works by suppressing appetite, improving satiety, and increasing energy expenditure

2. Improved Blood Sugar Control

  • Strong reduction in HbA1c in patients with type 2 diabetes

  • Enhances insulin secretion and reduces glucose production

  • May help reduce or eliminate the need for other diabetes medications in some individuals

3. Metabolic Improvements

  • Reduction in visceral fat

  • Lower fasting glucose and insulin levels

  • Improved markers of cardiometabolic health (cholesterol, triglycerides)

4. Potential Cardiovascular Benefits

  • Weight loss + improved metabolic profile may translate to reduced cardiovascular risk

  • Formal cardiovascular outcome trials are still needed

5. Liver Health

  • Significant reductions in liver fat

  • Shows promise for treating metabolic-associated steatohepatitis (MASH / fatty liver disease)

6. Increased Energy Expenditure

  • Unlike many weight‑loss medications, retatrutide stimulates glucagon receptors, which can increase calorie burning

‍ ‍intended strictly for laboratory research use and is not for human consumption or clinical application.

Main Benefits

1. Significant Weight Loss

  • Among the most substantial weight reductions seen in any obesity medication to date

  • Some participants lost over 24% of body weight at 48 weeks

  • Works by suppressing appetite, improving satiety, and increasing energy expenditure

2. Improved Blood Sugar Control

  • Strong reduction in HbA1c in patients with type 2 diabetes

  • Enhances insulin secretion and reduces glucose production

  • May help reduce or eliminate the need for other diabetes medications in some individuals

3. Metabolic Improvements

  • Reduction in visceral fat

  • Lower fasting glucose and insulin levels

  • Improved markers of cardiometabolic health (cholesterol, triglycerides)

4. Potential Cardiovascular Benefits

  • Weight loss + improved metabolic profile may translate to reduced cardiovascular risk

  • Formal cardiovascular outcome trials are still needed

5. Liver Health

  • Significant reductions in liver fat

  • Shows promise for treating metabolic-associated steatohepatitis (MASH / fatty liver disease)

6. Increased Energy Expenditure

  • Unlike many weight‑loss medications, retatrutide stimulates glucagon receptors, which can increase calorie burning

‍ ‍intended strictly for laboratory research use and is not for human consumption or clinical application.